# US 2005/0031718 A1 · Sea Buckthorn compositions and associated methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0031718 A1
- Document ID: US20050031718A1
- Status: Published application
- Kind: A1
- Application number: 10/821,262
- Filed: 2004-04-07
- Published: 2005-02-10
- Earliest claimed: 2003-04-10
- Assignees: Pharmanex, LLC
- Inventors: Jiashi Zhu; Yan Zhang
- Web page: https://patentgrep.com/patent/US20050031718A1

## CPC

- A61K 36/185: Magnoliopsida (dicotyledons)
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A23L 33/30: {Dietetic or nutritional methods, e.g. for losing weight (A23L33/10 takes precedence)}
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 36/61: Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)

## Abstract

Compositions having an effective amount of a Sea Buckthorn extract and an inert carrier and methods of use therefor are disclosed and described. Such methods of use include may include controlling serum lipid concentrations in a subject, and controlling the body weight of a subject, among others.

## Claims

### Claim 1

A method of controlling serum lipid concentrations in a subject comprising:
(a) providing a composition containing a therapeutically effective amount of a sea buckthorn extract and an inert carrier, and
(b) administering the composition to a subject.

### Claim 2 (depends on 1)

A method as in claim 1, wherein the controlling is reducing serum lipid concentrations in a subject.

### Claim 3 (depends on 2)

A method as in claim 2, wherein the serum lipid is a triglyceride.

### Claim 4 (depends on 2)

A method as in claim 2, wherein the serum lipid is total cholesterol.

### Claim 5 (depends on 2)

A method as in claim 2, wherein the serum lipid is a low-density lipoprotein.

### Claim 6 (depends on 1)

A method as in claim 1, wherein the controlling is preventing a concentration increase in a serum lipid selected from the group consisting of triglycerides, cholesterol, low density lipoprotein, and combinations thereof.

### Claim 7 (depends on 1)

A method as in claim 1, wherein the controlling is elevating high density lipoprotein serum concentrations.

### Claim 8 (depends on 1)

A method as in claim 1, wherein the inert carrier is selected from the group consisting of calcium carbonate, calcium silicate, calcium magnesium silicate, calcium phosphate, kaolin, sodium hydrogen carbonate, sodium sulfate, barium carbonate, barium sulfate, magnesium sulfate, magnesium carbonate, activated carbon, water, isopropyl alcohol, ethyl alcohol, polyvinyl pyrrolidone, propylene glycol, polyethylene glycol stearyl alcohol, stearic acid, sorbitan monooleate, microcrystalline cellulose, sodium carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, sorbitol, mannitol, xylitol, starches, gelatins, lactose, acacia, carbomer, dextrin, guar gum, lactose, liquid glucose, maltodextrin, polymethacrylates, and combinations thereof.

### Claim 9 (depends on 1)

A method as in claim 1, wherein the sea buckthorn extract is administered orally.

### Claim 10 (depends on 9)

A method as in claim 9, wherein the oral administration is performed using a dosage form selected from the group consisting of beverages, effervescent beverages, liquids, syrups, elixirs, suspensions, tablets, powders, capsules, gel capsules, confections, candies, bars, lozenges, and combinations thereof.

### Claim 11 (depends on 1)

A method as in claim 1, wherein the composition further comprises an active ingredient selected from the group consisting of herbal extracts, botanical extracts, vitamins, minerals, amino acids, proteins, enzymes, and combinations thereof.

### Claim 12 (depends on 1)

A method as in claim 1, wherein the composition further comprises a cortisol controlling agent selected from the group consisting of ashwagandha, beta-sitosterol, Epimedium, garlic, L-theanine, magnolia bark extract, phosphatidylserine, and combinations thereof.

### Claim 13

A method of controlling the body weight of a subject comprising:
(a) providing a composition containing a therapeutically effective amount of sea buckthorn extract and an inert carrier, and
(b) administering the composition to a subject.

### Claim 14 (depends on 13)

A method as in claim 13, wherein the controlling is reducing the body weight of the subject.

### Claim 15 (depends on 13)

A method as in claim 13, wherein the controlling is preventing the body weight of the subject from increasing.

### Claim 16 (depends on 13)

A method as in claim 13, wherein the therapeutically effect amount of sea buckthorn extract increases serum cholecystokinin concentration in the subject.

### Claim 17 (depends on 16)

A method as in claim 16, wherein the cholecystokinin serum concentration increase occurs by stimulating cholecystokinin production.

### Claim 18 (depends on 16)

A method as in claim 16, wherein the cholecystokinin serum concentration increase occurs by an increased rate in the release from cholecystokinin producing cells.

### Claim 19 (depends on 16)

A method as in claim 16, wherein the increased cholecystokinin serum concentration causes appetite suppression.

### Claim 20 (depends on 13)

A method as in claim 13, wherein administering the composition to the subject is part of a sustained dosing regimen.

### Claim 21 (depends on 20)

A method as in claim 20, wherein the regimen is less than about 1 year.

### Claim 22 (depends on 21)

A method as in claim 21, wherein the regimen is less than about 6 months.

### Claim 23 (depends on 22)

A method as in claim 22, wherein the regimen is less than about 3 months.

### Claim 24 (depends on 23)

A method as in claim 23, wherein the regimen is less than about 1 month.

### Claim 25 (depends on 13)

A method as in claim 13, wherein administering the composition to the subject includes a single daily dose.

### Claim 26 (depends on 13)

A method as in claim 13, wherein administering the composition to the subject includes multiple doses per day.

### Claim 27 (depends on 13)

A method as in claim 13, wherein the inert carrier is selected from the group consisting of calcium carbonate, calcium silicate, calcium magnesium silicate, calcium phosphate, kaolin, sodium hydrogen carbonate, sodium sulfate, barium carbonate, barium sulfate, magnesium sulfate, magnesium carbonate, activated carbon, water, isopropyl alcohol, ethyl alcohol, polyvinyl pyrrolidone, propylene glycol, polyethylene glycol stearyl alcohol, stearic acid, sorbitan monooleate, microcrystalline cellulose, sodium carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, sorbitol, mannitol, xylitol, starches, gelatins, lactose, acacia, carbomer, dextrin, guar gum, lactose, liquid glucose, maltodextrin, polymethacrylates, and combinations thereof.

### Claim 28 (depends on 13)

A method as in claim 13, wherein the sea buckthorn extract is administered orally.

### Claim 29 (depends on 28)

A method as in claim 28, wherein the oral administration is performed using a dosage form selected from the group consisting of beverages, effervescent beverages, liquids, syrups, elixirs, suspensions, tablets, powders, capsules, gel capsules, confections, candies, bars, lozenges, and combinations thereof.

### Claim 30 (depends on 13)

A method as in claim 13, wherein the composition further comprises an active ingredient selected from the group consisting of herbal extracts, botanical extracts, vitamins, minerals, amino acids, proteins, enzymes, and combinations thereof.

### Claim 31 (depends on 13)

A method as in claim 13, wherein the composition further comprises a cortisol controlling agent selected from the group consisting of ashwagandha, beta-sitosterol, Epimedium, garlic, L-theanine, magnolia bark extract, phosphatidylserine, and combinations thereof.

### Claim 32

A sea buckthorn composition comprising
(a) a therapeutically effective amount of sea buckthorn extract; and
(b) an inert carrier.

### Claim 33 (depends on 32)

A composition as in claim 32, wherein the inert carrier is selected from the group consisting of calcium carbonate, calcium silicate, calcium magnesium silicate, calcium phosphate, kaolin, sodium hydrogen carbonate, sodium sulfate, barium carbonate, barium sulfate, magnesium sulfate, magnesium carbonate, activated carbon, water, isopropyl alcohol, ethyl alcohol, polyvinyl pyrrolidone, propylene glycol, polyethylene glycol stearyl alcohol, stearic acid, sorbitan monooleate, microcrystalline cellulose, sodium carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, sorbitol, mannitol, xylitol, starches, gelatins, lactose, acacia, carbomer, dextrin, guar gum, lactose, liquid glucose, maltodextrin, polymethacrylates, and combinations thereof.

### Claim 34 (depends on 32)

A composition as in claim 32, wherein the composition is a dosage form selected from the group consisting of beverages, effervescent beverages, liquids, syrups, elixirs, suspensions, tablets, powders, capsules, gel capsules, confections, candies, bars, lozenges, and combinations thereof.

### Claim 35 (depends on 32)

A composition as in claim 32, wherein the composition further comprises an active ingredient selected from the group consisting of herbal extracts, botanical extracts, vitamins, minerals, amino acids, proteins, enzymes, and combinations thereof.

### Claim 36 (depends on 32)

A composition as in claim 32, wherein the composition further comprises a cortisol controlling agent selected from the group consisting of ashwagandha, beta-sitosterol, Epimedium, garlic, L-theanine, magnolia bark extract, phosphatidylserine, and combinations thereof.

### Claim 37 (depends on 32)

A composition as in claim 32, wherein the sea buckthorn extract is obtained from a portion of the sea buckthorn plant selected from the group consisting of the sea buckthorn fruit, the sea buckthorn leaves, the sea buckthorn stems and branches, the sea buckthorn seeds, and combinations thereof.

### Claim 38 (depends on 32)

A composition as in claim 32, wherein the composition reduces serum lipid concentrations in a subject in need thereof when administered to said subject.

### Claim 39 (depends on 32)

A composition as in claim 32, wherein the composition reduces the body weight of a subject in need thereof when administered to said subject.

### Claim 40 (depends on 32)

A composition as in claim 32, wherein the composition increases the serum concentration of cholecystokinin in the subject when administered to said subject.
